Akums Drugs and Pharmaceuticals Ltd (AKUM)

NSE
Currency in INR
566.20
+15.30(+2.78%)
Real-time Data·
AKUM Scorecard
Full Analysis
Prominent player in the Life Sciences Tools & Services industry
Unusual trading volume
Fair Value
Day's Range
550.00592.00
52 wk Range
405.001,175.90
Key Statistics
Edit
Bid/Ask
566.20 / 566.35
Prev. Close
550.9
Open
556.55
Day's Range
550-592
52 wk Range
405-1,175.9
Volume
945.46K
Average Volume (3m)
290.53K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AKUM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
750.00
Upside
+32.46%
Members' Sentiments
Bearish
Bullish
ProTips
Operates with a moderate level of debt

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Akums Drugs and Pharmaceuticals Ltd Company Profile

Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. The company provides drugs, ayurvedic, herbals, toiletries, nutraceuticals, food and dietary supplements, derma and cosmetics, healthcare and hospital products, over-the-counter (OTC) products, active pharmaceutical ingredients, excipients, and compounds. It also offers branded formulations on various dosage forms, including tablets, capsules, injectables, opthalmics, and soft gelatin capsules for therapeutic areas, such as gynaecology, cardiology, orthopaedics, pediatrics, and dermatology, as well as anti-infectives, pain management and gastroenterology. In addition, the company operates as pharmaceutical contract development and manufacturing company. The company was incorporated in 2004 and is based in Delhi, India.

Employees
7536
Market
India

Compare AKUM to Peers and Sector

Metrics to compare
AKUM
Peers
Sector
Relationship
P/E Ratio
24.9x32.2x−0.5x
PEG Ratio
0.000.840.00
Price/Book
2.8x4.4x2.6x
Price / LTM Sales
2.0x4.8x3.1x
Upside (Analyst Target)
26.5%1.1%45.7%
Fair Value Upside
Unlock6.7%5.7%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 750.00
(+32.46% Upside)

Earnings

Latest Release
May 26, 2025
EPS / Forecast
8.90 / --
Revenue / Forecast
10.58B / --
EPS Revisions
Last 90 days

AKUM Income Statement

People Also Watch

1,295.30
EMCU
+0.96%
1,343.30
RRKA
-0.09%
1,537.90
RAIB
+0.18%
1,016.00
JYCA
-1.36%

FAQ

What Is the Akums Drugs and Pharmaceuticals (AKUM) Stock Price Today?

The Akums Drugs and Pharmaceuticals stock price today is 566.20

What Stock Exchange Does Akums Drugs and Pharmaceuticals Trade On?

Akums Drugs and Pharmaceuticals is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Akums Drugs and Pharmaceuticals?

The stock symbol for Akums Drugs and Pharmaceuticals is "AKUM."

What Is the Akums Drugs and Pharmaceuticals Market Cap?

As of today, Akums Drugs and Pharmaceuticals market cap is 84.34B.

What Is Akums Drugs and Pharmaceuticals's Earnings Per Share (TTM)?

The Akums Drugs and Pharmaceuticals EPS (TTM) is 22.60.

When Is the Next Akums Drugs and Pharmaceuticals Earnings Date?

Akums Drugs and Pharmaceuticals will release its next earnings report on 02 Sept 2025.

From a Technical Analysis Perspective, Is AKUM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Akums Drugs and Pharmaceuticals Stock Split?

Akums Drugs and Pharmaceuticals has split 0 times.

How Many Employees Does Akums Drugs and Pharmaceuticals Have?

Akums Drugs and Pharmaceuticals has 7536 employees.

What is the current trading status of Akums Drugs and Pharmaceuticals (AKUM)?

As of 10 July 2025, Akums Drugs and Pharmaceuticals (AKUM) is trading at a price of 566.20, with a previous close of 550.90. The stock has fluctuated within a day range of 550.00 to 592.00, while its 52-week range spans from 405.00 to 1,175.90.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.